Description
Description
This page contains brief details about the drug rasburicase, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Rasburicase is an antihyperuricemic drug that belongs to the category of medicines known as uricolytic agents. It was approved by the U.S. FDA on 12th of July 2002 to treat high uric acid levels in chemotherapy.
Mechanism of Action of Rasburicase
It works by converting uric acid into allantoin, a more soluble compound that can be easily excreted by the kidneys. This reduces the levels of uric acid in the blood and prevents the development of hyperuricemia.
Uses of Rasburicase
Rasburicase is used to prevent or treat hyperuricemia that can occur as a result of cancer chemotherapy.
Rasburicase Dosage available
The medicine will be administered to you by a healthcare professional in a hospital setting. Rasburicase is given as an injection into a vein (intravenous infusion) over a period of 30 minutes, once a day for up to 5 days. The dose, route of administration, and frequency will be decided by your doctor based on your disease condition and other factors.
